Scarica l'app Stockscreener
99.02
1.97%
-1.99
Dopo l'orario di chiusura:
99.02
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$101.01
Aprire:
$101.06
Volume 24 ore:
7.74M
Relative Volume:
0.83
Capitalizzazione di mercato:
$146.79B
Reddito:
$19.35B
Utile/perdita netta:
$2.78B
Rapporto P/E:
52.96
EPS:
1.8696
Flusso di cassa netto:
$3.82B
1 W Prestazione:
-2.31%
1M Prestazione:
-1.69%
6M Prestazione:
-4.94%
1 anno Prestazione:
+9.50%
Intervallo 1D:
$98.99
$101.82
Intervallo di 1 settimana:
$98.99
$101.91
Portata 52W:
$85.98
$109.50
Boston Scientific Corp Stock (BSX) Company Profile
Nome
Boston Scientific Corp
Settore
Industria
Telefono
508-683-4000
Indirizzo
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
Confronta BSX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BSX
Boston Scientific Corp
|
99.02 | 149.74B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
ABT
Abbott Laboratories
|
126.32 | 222.59B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
366.68 | 142.38B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
102.03 | 132.48B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.71 | 49.48B | 5.88B | 1.34B | 799.60M | 2.3489 |
Boston Scientific Corp Stock (BSX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-03 | Downgrade | Erste Group | Buy → Hold |
| 2025-09-08 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-06-16 | Iniziato | Leerink Partners | Outperform |
| 2025-04-16 | Aggiornamento | Needham | Hold → Buy |
| 2025-01-10 | Aggiornamento | Deutsche Bank | Hold → Buy |
| 2024-10-18 | Downgrade | Needham | Buy → Hold |
| 2024-05-30 | Iniziato | Goldman | Buy |
| 2024-02-01 | Aggiornamento | Mizuho | Neutral → Buy |
| 2023-07-19 | Iniziato | Robert W. Baird | Outperform |
| 2023-06-30 | Iniziato | CL King | Buy |
| 2023-05-30 | Ripresa | Morgan Stanley | Overweight |
| 2023-03-29 | Iniziato | UBS | Buy |
| 2022-12-22 | Iniziato | Mizuho | Neutral |
| 2022-12-20 | Ripresa | Citigroup | Buy |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-07-06 | Iniziato | Wolfe Research | Outperform |
| 2022-05-27 | Aggiornamento | Needham | Hold → Buy |
| 2022-04-13 | Ripresa | Truist | Buy |
| 2022-03-02 | Ripresa | BofA Securities | Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-05-26 | Downgrade | Needham | Buy → Hold |
| 2021-05-25 | Iniziato | Barclays | Overweight |
| 2021-04-15 | Iniziato | Atlantic Equities | Overweight |
| 2020-09-17 | Iniziato | Truist | Buy |
| 2020-09-11 | Iniziato | Wolfe Research | Peer Perform |
| 2020-04-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-03-05 | Iniziato | Citigroup | Buy |
| 2020-02-13 | Iniziato | Goldman | Neutral |
| 2020-02-06 | Ripresa | BTIG Research | Buy |
| 2019-12-30 | Reiterato | Cowen | Outperform |
| 2019-12-19 | Downgrade | Needham | Strong Buy → Buy |
| 2019-09-05 | Ripresa | JP Morgan | Overweight |
| 2019-09-03 | Ripresa | Barclays | Overweight |
| 2019-05-13 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2018-11-28 | Iniziato | UBS | Buy |
| 2018-10-16 | Iniziato | Barclays | Overweight |
| 2018-10-02 | Reiterato | Morgan Stanley | Overweight |
| 2018-09-07 | Reiterato | Needham | Strong Buy |
| 2018-09-04 | Aggiornamento | Jefferies | Hold → Buy |
| 2018-07-06 | Reiterato | Needham | Strong Buy |
| 2018-06-27 | Iniziato | Bernstein | Outperform |
| 2018-04-26 | Reiterato | Needham | Strong Buy |
Mostra tutto
Boston Scientific Corp Borsa (BSX) Ultime notizie
Boston Sci's Farapoint secures CE mark - BioWorld MedTech
This investor loves Boston Scientific - Cantech Letter
Will Boston Scientific Corporation stock outperform tech sector in 2025Quarterly Trade Summary & Short-Term High Return Strategies - BỘ NỘI VỤ
What Could Shift the Story for Boston Scientific After Strong Results and Analyst Optimism - Yahoo Finance
How buybacks impact Boston Scientific Corporation stock value2025 Market Sentiment & Real-Time Volume Analysis - BỘ NỘI VỤ
Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic? - Finviz
Why Boston Scientific (BSX) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Is Boston Scientific Stock Underperforming the Nasdaq? - Barchart.com
Why this money manager is buying Boston Scientific and trimming BlackRock - The Globe and Mail
Is Boston Scientific (NYSE:BSX) A Risky Investment? - Yahoo Finance
Boston Scientific Corp. stock outperforms competitors on strong trading day - MarketWatch
Boston Scientific's Margins Strengthen in Q3: What's Driving It? - Yahoo Finance
Boston Scientific (NYSE:BSX) Trading Volume Rises After Sector-Focused Report - Kalkine Media
Q3 Earnings Roundup: Boston Scientific (NYSE:BSX) And The Rest Of The Medical Devices & SuppliesDiversified Segment - Yahoo Finance
Boston Scientific Corp. stock rises Monday, still underperforms market - MarketWatch
Boston Scientific (BSX): Evaluating Valuation as Investors Weigh Growth and Competitive Position - Yahoo Finance
Boston Scientific (BSX) Down 5.7% Since Last Earnings Report: Can It Rebound? - Yahoo Finance
Analysts project durable growth with many near-term catalysts for Boston Scientific - MassDevice
BTIG Reiterates Boston Scientific (BSX) Buy Recommendation - Nasdaq
Internal Neuromodulation Devices Market Poised to Exceed USD 44.57 Billion by 2033 | Astute Analytica - GlobeNewswire Inc.
Can Boston Scientific Corporation stock sustain institutional flowsMarket Activity Report & AI Driven Stock Reports - newser.com
Will Boston Scientific Corporation stock benefit from automation - newser.com
Boston Scientific Corporation's (NYSE:BSX) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong? - Yahoo Finance
Is Boston Scientific Corporation stock undervalued after correctionJuly 2025 Big Picture & Safe Entry Momentum Tips - newser.com
Boston Scientific Corp. Stock Outperforms Competitors Despite Losses On The Day - 富途牛牛
Boston Scientific (BSX) Announces 2026 Compensation Plans to Dri - GuruFocus
Boston Scientific, Epic collaborate on cardiac diagnostic EHR services - MassDevice
Boston Scientific Approves 2026 Bonus Plan - TipRanks
[8-K] BOSTON SCIENTIFIC CORP Reports Material Event | BSX SEC FilingForm 8-K - Stock Titan
Boston Scientific (BSX) Stock Today: Price Slips as Neuromodulation Bull Case, Epic EHR Deal and Big Fund Moves Shape the Outlook – November 19, 2025 - ts2.tech
Siemens partners with Boston Sci, eyes standalone growth - BioWorld MedTech
Using AI based signals to follow Boston Scientific Corporation2025 Performance Recap & Advanced Technical Analysis Signals - newser.com
Can Boston Scientific Corporation stock deliver consistent EPS growth2025 Sector Review & Daily Chart Pattern Signal Reports - newser.com
Does Boston Scientific Corporation stock trade at a discount to peersWeekly Volume Report & Entry and Exit Point Strategies - newser.com
Boston Scientific at Wolfe Conference: Innovation and Market Growth - Investing.com
Wall Street Analysts Believe Boston Scientific (BSX) Could Rally 25.34%: Here's is How to Trade - Finviz
Zacks Industry Outlook Highlights Boston Scientific, Insulet, BioLife Solutions and Allurion - Nasdaq
Boston Scientific, Siemens Healthineers partner on cardiac catheter - Yahoo Finance
Can Boston Scientific Corporation recover in the next quarterNew Guidance & Free Accurate Trade Setup Notifications - newser.com
Why Boston Scientific Corporation stock is favored by hedge fundsWeekly Trade Report & Free High Accuracy Swing Entry Alerts - newser.com
2 Reasons to Watch BSX and 1 to Stay Cautious - Finviz
What earnings revisions data tells us about Boston Scientific Corporation2025 Retail Activity & Risk Controlled Daily Trade Plans - newser.com
Is Boston Scientific's Valuation Justified After 18% Gain and New Product Launches? - Yahoo Finance
What Boston Scientific (BSX)'s Surging Sales and Siemens Partnership Mean for Shareholders - Yahoo! Finance Canada
[Form 4] BOSTON SCIENTIFIC CORP Insider Trading Activity - Stock Titan
Boston Scientific Corp. stock underperforms Friday when compared to competitors - MarketWatch
Boston Scientific Corp Azioni (BSX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Boston Scientific Corp Azioni (BSX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Zane Ellen M | Director |
Nov 06 '25 |
Sale |
98.28 |
12,891 |
1,266,978 |
24,134 |
| Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Nov 03 '25 |
Option Exercise |
26.15 |
50,000 |
1,307,500 |
228,342 |
| Fitzgerald Joseph Michael | EVP & Group Pres, Cardiology |
Nov 03 '25 |
Sale |
99.47 |
50,000 |
4,973,338 |
178,342 |
1.51%
1.24%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):